Department of Internal Medicine UI awarded $33.8 million for clinical and translational research ![]() Gary W. Hunninghake, M.D. Sterba Professor of Medicine Director, Division of Pulmonary, Critical Care, and Occupational Medicine
9/18/2007 The National Institutes of Health (NIH) today announced the University of Iowa as one of 12 academic health centers nationwide to receive a Clinical and Translational Science Award (CTSA). The five-year, $33.8 million award is the second-largest research award in UI history. The CTSA will support the University's Institute for Clinical and Translational Science, formally approved by the Board of Regents, State of Iowa in December 2006, to expand and enhance "bench-to-bedside" research -- laboratory discoveries that lead to patient-based studies in clinical settings. "The University of Iowa is the recipient, but the planning and application for this award came from the entire state of Iowa. Over the past two years we have worked to create a statewide network of hospitals, physicians and community health centers that will participate in the Institute," said UI President Sally Mason. "The fact that we are among an elite group of institutions to receive a CTSA is yet another indication of our status as one of the nation's top research universities." "This major award from NIH marks a new era in health care in Iowa," said Jean Robillard, M.D., vice president for medical affairs and dean of the Roy J. and Lucille A. Carver College of Medicine. "Because of this award and the Institute it supports, new therapies based on cutting-edge research discoveries will be more readily available to Iowans through their local hospitals and physicians who are part of this statewide research network." Meredith Hay, Ph.D., UI vice president for research, noted that the CTSA and the Institute for Clinical and Translational Science reflect the most comprehensive collaboration in the history of the university, one that will involve all 11 of the UI colleges and nearly 40 centers and institutes, as well as Iowa State University and the University of Arizona. "The UI's tradition in multi- and interdisciplinary research was no doubt a key strength in our application," Hay said. "The NIH is committed to turning the latest scientific advances into new treatments as quickly and efficiently as possible. With this award -- and the research collaborations and partnerships that follow -- we will play an important role in making this happen. This is a tremendous opportunity for the state of Iowa." As part of its mission, the UI Institute for Clinical and Translational Science will:
More than 150 UI researchers, administrators and staff members, and collaborators from around the state, were involved in preparing the CTSA proposal to the NIH, beginning in 2005, noted Gary Hunninghake, M.D., the Carver College of Medicine's associate dean for clinical and translational science and director the Institute. "This has been a detailed, coordinated effort involving the work of many colleagues and partners," said Hunninghake, who also is the Sterba Professor of Internal Medicine at the UI. "We have formed an incredible team of researchers, clinicians, administrators and community leaders around the state -- all working together to improve the health of Iowans and the world." Additional Information
|


